Brain Resource (BRC)

Shares / Stock Code

BRC

Stock Exchange / Sharemarket

ax

Brain Resource (BRC) is an international brain service company. It has developed a non-invasive method of diagnosing brain function disorders with the help of a computer software that analyses the patterns of electrical activity generated in a patient's brain in comparison with the patterns generated in brains of healthy individuals. BRC was listed on the Australian stock market in August 2001. Its headquarters are situated in Sydney. The company is an advanced business partner of IBM. BRC was renamed to its current name in May 2008. Investors can trade shares on the Australian Stock Exchange (ASX).

Brain Resource (BRC) provides evidence-based reports about brain function. The company has set up an international standardised human brain database to deliver evidence-based findings about the brain. In-depth analyses deliver findings on brain functionability to various factors such as personalised medicine, aging, disease, occupational hazards and peak performance.

Major customers include the general public of all ages. However, BRC's service focuses mainly on hospital patients with disorders such as ADHD, early Alzheimer's dementia, PTSD, sleep apnea, schizophrenia and traumatic brain injury. Competitors would mainly include research institutes specialising in brain function.

Brain Resource has collected over 50,000 datasets. There are over 4,000 healthy controls from the age of 6-100 in their normative database as well as large and growing clinical databases in Depression, Schizophrenia, Mild Cognitive Impairment, PTSD, ADHD and Brain Injury. Test standardization ensures total quality control and robust representative profiles in each disorder.

Database growth is achieved through funded studies and a collaborative research network. No data is added to or leaves the BRID without subject consent and independent ethics approval. The BRID and Brain Resource methodology has provided the basis for over 450 peer-reviewed publications. Independent Scientists are invited to apply for access to data in the BRID to test their own hypotheses for publication purposes.